Table 1.
Summary of cases. Plasma results of sodium, potassium, bicarbonate and pH are from the day of presentation, unless indicated. Initial urinary electrolytes, renin and aldosterone concentrations are from the initial admission
Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | |
---|---|---|---|---|---|---|---|
Age at presentation (days) | 25 | 28 | 8 | 23 | 10 | 5 | 10 |
Symptoms | Vomiting and weight loss | Weight loss and poor feeding | Weight loss | Vomiting and weight loss | Inpatient | Jaundice and weight loss | Weight loss and drowsiness |
Plasma Na (mmol/l) (RR 135–145) | 119 | 126 | 118 | 118 | 109 | 142 (112 on D10) | 126 |
Plasma K (mmol/l) (RR 3.5–5) | NA | 6.8 | 8.2 | 7.3 | 6.8 | 6.1 (11.3 on D10) | 10 |
Plasma HCO3− (mmol/l) (RR 17–25) | 19.4 | 17.9 | 19.6 | NA | 18.6 | 19.3 (D10) | 10.4 |
pH | 7.39 | 7.27 | NA | NA | 7.27 | 7.38 | 7.21 |
Creatinine (μmol/l) (RR 37–89) | 67 | 61 | 29 | 48 | 96 | 74 (87 on D10) | 49 (D11) |
Urine K (mmol/l) | 37 | 20 | NA | 19 (24) | 10 | 22 | 7 (D15) |
Urine Na (mmol/l) | 50 | 16 | 15 | 20 (D24) | 35 | 111 | 142 (D15) |
Serum aldosterone (pmol/l) (RR 400–3000) | 35 700 | 39 900 | 83 390 | 48 000 | 49 500 | 57 000 | 16 580 |
PRA (nmol/l per h) (RR 1.9–29) | 41.3 | 250 | >250 | 16 | >250 | >250 | 131.5 |
Duration of follow-up (months) | 62 | 38 | 25 | 14 | 36 | 39 | 42 |
Weight centile at last clinic appointment | 91st–98th | 9th–25th | 25th | 50th | 91st–98th | 9th | 75th |
Ongoing management | Initial Na supplementation 2.5 mmol/kg per day | Initial Na supplementation 1.5 mmol/kg per day | Initial Na supplementation 2 mmol/kg per day | Discharged from follow-up. Not on medication | Initial Na supplementation 4 mmol/kg per day | Initial Na supplementation 3.8 mmol/kg per day* | Na supplements 8.5 mmol/kg per day* |
Now on 0.7 mmol/kg per day | Now on Na 0.7 mmol/kg per day | Now on Na 0.8 mmol/kg per day | NaHCO3 1.6 mmol/kg per day* | NaHCO3 2 mmol/kg per day* | |||
Indomethacin 1.5 mg/kg b.d. | Flucloxacillin 125 mg b.d. | ||||||
Gaviscon | Penicillin V 125 mg b.d. | ||||||
Ranitidine | Omeprazole 0.6 mg/kg b.d. | ||||||
Low potassium feeds | Domperidone 0.35 mg/kg b.d. | ||||||
Intermittent requirement for i.v. 0.9% NaCl | Montelukast 4 mg o.d. | ||||||
Beclometasone 200 μg b.d. | |||||||
Sodium cromoglycate 5 mg q.d.s. | |||||||
Low potassium feeds | |||||||
PRA (nmol/l per h) after long-term management | 6.1 | 24.9 | NA | 7.4 | 1.1 | 0.3 | Not done |
Aldosterone (pmol/l) after long-term management | 1230 | 5450 | 23.3 | 3400 | 385 | <55 | Not done |
Renal and bladder USS | Normal | Normal | Normal | Normal | Normal | Normal | Normal |
RR, reference range (age appropriate); PRA, plasma renin activity; NA, not available; o.d., once daily; b.d., twice daily; q.d.s., four times daily; USS, ultrasound scan.
Doses subject to variation.